'Therapeutic potential of dichloroacetate for pyruvate dehydrogenase complex deficiency'

Remy

Administrator
Abstract
We reviewed the use of oral dichloroacetate (DCA) in the treatment of children with congenital lactic acidosis caused by mutations in the pyruvate dehydrogenase complex (PDC). The case histories of 46 subjects were analyzed with regard to diagnosis, clinical presentation and response to DCA.

DCA decreased blood and cerebrospinal fluid lactate concentrations, and was generally well tolerated. DCA may be particularly effective in children with PDC deficiency by stimulating residual enzyme activity and, consequently, cellular energy metabolism.

A controlled trial is needed to determine the definitive role of DCA in the management of this devastating disease.

PM me for full text.
 

Support Our Work

Health Rising’s Quickie 2025 Summer Donation Drive Has Begun!

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Get Our Free ME/CFS and FM Blog!

Forum Tips

Shopping on Amazon.com For HR

Latest Resources

Top